Arran Babbs

1.2k citations

18 papers · 950 indexed · h-index 15

Molecular Biology top 10%
Genetics top 10%
Cellular and Molecular Neuroscience top 10%
Genetics top 10%
Physiology

Co-authors: Kay E. Davies Aurélie Goyenvalle Luis Garcı́a Matthew J. A. Wood D. Powell Sarah Squire J. Claire Wright Simon Guiraud
Topics: Muscle Physiology and Disorders (14 papers)Virus-based gene therapy research (5 papers)RNA Interference and Gene Delivery (5 papers)
Cited by: Aging Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nature Medicine Scientific Reports
Partner nations: United Kingdom France United States

In The Last Decade

Arran Babbs

18 papers receiving 942 citations

Peers

Countries citing papers authored by Arran Babbs

Since Specialization

Citations

This map shows the geographic impact of Arran Babbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arran Babbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arran Babbs more than expected).

Fields of papers citing papers by Arran Babbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arran Babbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arran Babbs. The network helps show where Arran Babbs may publish in the future.

Co-authorship network of co-authors of Arran Babbs

This figure shows the co-authorship network connecting the top 25 collaborators of Arran Babbs. A scholar is included among the top collaborators of Arran Babbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arran Babbs. Arran Babbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy 2020 ·Journal of Medicinal Chemistry ·Arran Babbs,Adam Berg,Maria Chatzopoulou,Kay E. Davies,Stephen G. Davies,Benjamin Edwards,(unknown),Enrico Emer,Simon Guiraud,Shawn Harriman,(unknown),Lee Moir,David G. Peters,(unknown),Jessica A. Rowley,Angela J. Russell,Sarah Squire,Jonathon M. Tinsley,Francis X. Wilson,Graham M. Wynne	15
2	From diagnosis to therapy in Duchenne muscular dystrophy 2020 ·Biochemical Society Transactions ·Arran Babbs,Maria Chatzopoulou,Ben Edwards,Sarah Squire,(unknown),Graham M. Wynne,Angela J. Russell,Kay E. Davies	18
3	The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy 2019 ·Human Molecular Genetics ·Simon Guiraud,Benjamin Edwards,Arran Babbs,Sarah Squire,Adam Berg,Lee Moir,Matthew J. A. Wood,Kay E. Davies	34
4	Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice 2018 ·Molecular Therapy — Methods & Clinical Development ·(unknown),Simon Guiraud,Benjamin Edwards,Sarah Squire,Lee Moir,Arran Babbs,Guy L. Odom,Diane Golebiowski,Joel Schneider,Jeffrey S. Chamberlain,Kay E. Davies	23
5	Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD 2018 ·Human Molecular Genetics ·Simon Guiraud,Benjamin Edwards,Sarah Squire,Lee Moir,Adam Berg,Arran Babbs,(unknown),Matthew J. A. Wood,Kay E. Davies	29
6	Identification of serum protein biomarkers for utrophin based DMD therapy 2017 ·Scientific Reports ·Simon Guiraud,Benjamin Edwards,Sarah Squire,Arran Babbs,(unknown),Adam Berg,(unknown),Kay E. Davies	28
7	Identification of serum protein biomarkers for utrophin based DMD therapy 2017 ·Neuromuscular Disorders ·Simon Guiraud,Ben Edwards,Sarah Squire,Arran Babbs,(unknown),(unknown),H. Chen,Kay E. Davies	1
8	Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers 2015 ·Nature Medicine ·Aurélie Goyenvalle,Graziella Griffith,Arran Babbs,Samir EL Andaloussi,Kariem Ezzat,(unknown),Branislav Dugovič,Rémi Chaussenot,Arnaud Ferry,Thomas Voït,Helge Amthor,Claudia Bühr,Stefan Schürch,Matthew J. A. Wood,Kay E. Davies,Cyrille Vaillend,Christian J. Leumann,Luis Garcı́a	240
9	Second-generation compound for the modulation of utrophin in the therapy of DMD 2015 ·Human Molecular Genetics ·Simon Guiraud,Sarah Squire,Benjamin Edwards,(unknown),D T Burns,(unknown),Arran Babbs,Stephen G. Davies,Graham M. Wynne,Angela J. Russell,(unknown),Francis X. Wilson,Jon Tinsley,Kay E. Davies	67
10	Temporal transcriptomics suggest that twin-peaking genes reset the clock 2015 ·eLife ·William G. Pembroke,Arran Babbs,Kay E. Davies,Chris P. Ponting,Peter L. Oliver	60
11	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping 2012 ·Human Molecular Genetics ·Aurélie Goyenvalle,Arran Babbs,J. Claire Wright,Vivienne Wilkins,D. Powell,Luis Garcı́a,Kay E. Davies	81
12	Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy 2012 ·Molecular Therapy ·Aurélie Goyenvalle,J. Claire Wright,Arran Babbs,Vivienne Wilkins,Luis Garcı́a,Kay E. Davies	45
13	The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery 2012 ·Molecular Therapy — Nucleic Acids ·(unknown),Julie Tordo,Arran Babbs,Kay E. Davies,Aurélie Goyenvalle,Olivier Danos	11
14	T.O.3 Tricyclo-DNA: A promising chemistry for the synthesis of antisense molecules for splice-switching approaches in DMD 2012 ·Neuromuscular Disorders ·Aurélie Goyenvalle,Arran Babbs,(unknown),Gareth Griffiths,Branislav Dugovič,Kay E. Davies,Christian J. Leumann,Luis Garcı́a	3
15	Diaphragm rescue alone prevents heart dysfunction in dystrophic mice 2010 ·Human Molecular Genetics ·Alastair Crisp,HaiFang Yin,Aurélie Goyenvalle,Corinne Betts,Hong M. Moulton,Yiqi Seow,Arran Babbs,Thomas M. Merritt,Amer F. Saleh,Michael J. Gait,Daniel J. Stuckey,Kieran Clarke,Kay E. Davies,Matthew J. A. Wood	56
16	Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping 2009 ·Molecular Therapy ·Aurélie Goyenvalle,Arran Babbs,D. Powell,Ryszard Kole,Sue Fletcher,Steve D. Wilton,Kay E. Davies	84
17	Enhanced Exon-skipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy 2009 ·Molecular Therapy ·Aurélie Goyenvalle,Arran Babbs,Gert‐Jan B. van Ommen,Luis Garcı́a,Kay E. Davies	60
18	A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse 2007 ·Proceedings of the National Academy of Sciences ·Alexander Jeans,Peter L. Oliver,Reuben Johnson,Marco Capogna,Jenny Vikman,Zoltán Molnár,Arran Babbs,Christopher J. Partridge,Albert Salehi,Martin Bengtsson,Lena Eliasson,Patrik Rorsman,Kay E. Davies	95

About Arran Babbs

Arran Babbs is a scholar working on Rehabilitation, Geriatrics and Gerontology and Molecular Biology, having authored 18 papers that have together received 950 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (14 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Aging (22 citations), Genetics (132 citations) and Molecular Biology (808 citations). Arran Babbs has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Kay E. Davies, Aurélie Goyenvalle, Luis Garcı́a, Matthew J. A. Wood, D. Powell, Sarah Squire, J. Claire Wright, Simon Guiraud, Peter L. Oliver and Vivienne Wilkins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact